Comparison of Rifaximin and Lactulose for the Treatment of Hepatic Encephalopathy: A Prospective Randomized Study

Rifaximin has been reported to be effective for the treatment of hepatic encephalopathy (HE) in Europe. However, it is unknown whether Rifaximin is effective for the treatment of HE in Koreans, therefore we conducted a open-label prospective randomized study to evaluate the efficacy of rifaximin ver...

Descripción completa

Detalles Bibliográficos
Autores principales: Paik, Yong-Han, Lee, Kwan Sik, Han, Kwang-Hyub, Song, Kun Hoon, Kim, Myoung Hwan, Moon, Byung Soo, Ahn, Sang Hoon, Lee, Se Joon, Park, Hyo Jin, Lee, Dong Ki, Chon, Chae Yoon, Lee, Sang In, Moon, Young Myoung
Formato: Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2005
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815818/
https://www.ncbi.nlm.nih.gov/pubmed/15988813
http://dx.doi.org/10.3349/ymj.2005.46.3.399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815818/
https://www.ncbi.nlm.nih.gov/pubmed/15988813
http://dx.doi.org/10.3349/ymj.2005.46.3.399

Ejemplares similares